OCUL
NASDAQ · Pharmaceuticals
Ocular Therapeutix Inc
$9.19
+0.45 (+5.15%)
Open$8.80
Previous Close$8.74
Day High$9.20
Day Low$8.80
52W High$16.44
52W Low$6.23
Volume—
Avg Volume2.05M
Market Cap1.92B
P/E Ratio—
EPS$-1.46
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
+517.0% upside
Current
$9.19
$9.19
Target
$56.70
$56.70
$44.23
$56.70 avg
$95.28
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 65.20M | 65.00M | 384.00M |
| Net Income | -333,682,309 | -299,415,830 | 56.73M |
| Profit Margin | -511.9% | -486.3% | 14.8% |
| EBITDA | -333,376,890 | -315,760,763 | 95.97M |
| Free Cash Flow | — | — | 61.23M |
| Rev Growth | +0.3% | +0.3% | -3.5% |
| Debt/Equity | 0.11 | 0.11 | 0.35 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |